IP Library Granted Patent US 10,646,128
Granted Patent B2
US 10,646,128 · App. 15/433,502 · Granted May 12, 2020

Facilitating assessment of blood flow and tissue perfusion using fluorescence-mediated photoplethysmography

Inventors: Robert W. Flower (Hunt Valley, MD); Robert Anthony Stead (Vancouver, CA); Arthur E. Bailey (North Vancouver, CA)
Assignee: Novadaq Technologies ULC
A61B5/0261A61B5/0071A61B5/029A61B5/0275A61B5/02416A61B5/6826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,646,128
App. No.
15/433,502
Granted
May 12, 2020
Kind
B2
Abstract

Methods and systems for facilitating assessment of blood flow in a tissue volume of a subject are disclosed. In some variations, the method may include: after a predetermined amount of a fluorescence agent has been administered to the subject, exciting the fluorescence agent in the tissue volume such that the excited fluorescence agent emits fluorescent light, acquiring fluorescence data based on the fluorescent light emitted during blood flow through the tissue volume, estimating a molar concentration of the fluorescence agent in the blood flowing through the tissue volume, and generating an assessment of blood flow in the tissue volume based at least in part on the fluorescence data and the estimated molar concentration of the fluorescence agent. The estimated molar concentration may be based on the predetermined amount of the fluorescence agent and an estimated circulating blood volume of the subject.

Claims (43)

1. A system for facilitating assessment of blood flow in a tissue volume of a subject, the system comprising:

a light source configured to excite a fluorescence agent in the tissue volume, after a predetermined amount of the fluorescence agent has been administered to the subject, such that the fluorescence agent emits fluorescent light;

one or more processors; and

memory having instructions stored thereon, wherein the instructions, when executed by the one or more processors, cause the system to:

receive fluorescence data based on the fluorescent light emitted from the excited fluorescence agent in the tissue volume;

estimate a molar concentration of the fluorescence agent in the blood flowing through the tissue volume, wherein the estimated molar concentration is based on the predetermined amount of the fluorescence agent and an estimated circulating blood volume in the subject; and

generate an assessment of blood flow in the tissue volume based at least in part on the fluorescence data and the estimated molar concentration of the fluorescence agent.

2. The system of claim 1 , wherein the assessment of blood flow in the tissue volume is based on a cross-sectional area of the tissue volume, a thickness increase of a blood volume layer, a pulse duty cycle of blood flow, and duration of a single pressure pulse in blood flow.

3. The system of claim 2 , wherein generating the assessment of blood flow in the tissue volume comprises estimating the thickness increase of the blood volume layer based at least in part on an intensity of the fluorescence data during a diastolic phase of blood flow and the intensity of the fluorescence data during a systolic phase of blood flow.

4. The system of claim 3 , wherein the instructions cause the system to estimate the thickness increase of the blood volume layer based at least in part on the estimated molar concentration of the fluorescence agent.

5. The system of claim 1 , wherein the instructions cause the system to estimate the circulating blood volume in the subject.

6. The system of claim 5 , wherein the instructions cause the system to estimate the circulating blood volume based at least in part on sex, body height, and body weight.

7. The system of claim 1 , wherein the system facilitates assessment of blood perfusion in the tissue volume.

8. The system of claim 1 , wherein the tissue volume is selected in the fluorescence data by a user.

9. The system of claim 1 , wherein the fluorescence agent comprises indocyanine green.

10. The system of claim 1 , further comprising a sensor that acquires the fluorescence data based on the fluorescent light emitted during blood flow through the tissue volume.

11. A method for use in medical imaging for facilitating assessment of blood flow in a tissue volume of a subject, the method comprising:

after a predetermined amount of a fluorescence agent has been administered to the subject, exciting the fluorescence agent in the tissue volume such that the excited fluorescence agent emits fluorescent light;

acquiring fluorescence data based on the fluorescent light emitted during blood flow through the tissue volume;

estimating a molar concentration of the fluorescence agent in the blood flowing through the tissue volume, wherein the estimated molar concentration is based on the predetermined amount of the fluorescence agent and an estimated circulating blood volume in the subject; and

generating an assessment of blood flow in the tissue volume based at least in part on the fluorescence data and the estimated molar concentration of the fluorescence agent.

12. The method of claim 11 , wherein the assessment of blood flow in the tissue volume is based on a cross-sectional area of the tissue volume, a thickness increase of a blood volume layer, a pulse duty cycle of blood flow, and duration of a single pressure pulse in blood flow.

13. The method of claim 12 , wherein generating the assessment of blood flow in the tissue volume comprises estimating the thickness increase of the blood volume layer based at least in part on an intensity of the fluorescence data.

14. The method of claim 13 , wherein the assessment of blood flow in the tissue volume is based at least in part on the intensity of the fluorescence data during a diastolic phase of blood flow and the intensity of the fluorescence data during a systolic phase of blood flow.

15. The method of claim 13 , wherein the estimated thickness increase of the blood volume layer is based at least in part on the estimated molar concentration of the fluorescence agent.

16. The method of claim 11 , wherein the method further comprises estimating the circulating blood volume in the subject.

17. The method of claim 16 , wherein estimating the circulating blood volume in the subject comprises estimating the circulating blood volume based at least in part on sex, body height, and body weight.

18. The method of claim 11 , wherein the method facilitates assessment of blood perfusion in the tissue volume.

19. The method of claim 11 , wherein the tissue volume is selected in the fluorescence data by a user.

20. The method of claim 11 , wherein the fluorescence agent comprises indocyanine green.

21. A non-transitory computer-readable storage medium storing instructions for facilitating assessment of blood flow in a tissue volume of a subject, wherein the instructions, when executed by a system comprising a light source and one or more processors, cause a system to:

excite, by the light source, a fluorescence agent in the tissue volume, after a predetermined amount of the fluorescence agent has been administered to the subject, such that the fluorescence agent emits fluorescent light;

receive fluorescence data based on the fluorescent light emitted from the excited fluorescence agent in the tissue volume;

estimate a molar concentration of the fluorescence agent in the blood flowing through the tissue volume, wherein the estimated molar concentration is based on the predetermined amount of the fluorescence agent and an estimated circulating blood volume in the subject; and

generate an assessment of blood flow in the tissue volume based at least in part on the fluorescence data and the estimated molar concentration of the fluorescence agent.

22. The non-transitory computer-readable storage medium of claim 21 , wherein the assessment of blood flow in the tissue volume is based on a cross-sectional area of the tissue volume, a thickness increase of a blood volume layer, a pulse duty cycle of blood flow, and duration of a single pressure pulse in blood flow.

23. The non-transitory computer-readable storage medium of claim 22 , wherein generating the assessment of blood flow in the tissue volume comprises estimating the thickness increase of the blood volume layer based at least in part on an intensity of the fluorescence data during a diastolic phase of blood flow and the intensity of the fluorescence data during a systolic phase of blood flow.

24. The non-transitory computer-readable storage medium of claim 23 , wherein the instructions cause the system to estimate the thickness increase of the blood volume layer based at least in part on the estimated molar concentration of the fluorescence agent.

25. The non-transitory computer-readable storage medium of claim 21 , wherein the instructions cause the system to estimate the circulating blood volume in the subject.

26. The non-transitory computer-readable storage medium of claim 25 , wherein the instructions cause the system to estimate the circulating blood volume based at least in part on sex, body height, and body weight.

27. The non-transitory computer-readable storage medium of claim 21 , wherein the system facilitates assessment of blood perfusion in the tissue volume.

28. The non-transitory computer-readable storage medium of claim 21 , wherein the tissue volume is selected in the fluorescence data by a user.

29. The non-transitory computer-readable storage medium of claim 21 , wherein the fluorescence agent comprises indocyanine green.

Assignments (16)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0548. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/30/2017. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056425/0616 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICAITON NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053318 FRAME: 0612. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056425/0731 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052873 FRAME: 0597. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 09/05/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056426/0352 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 053823 FRAME: 0445. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 11/29/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056426/0496 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 052860 FRAME: 0900. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE 12/31/2018. Recorded May 3, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056426/0585 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ERRONEOUSLY FILED AGAINST APPLICATION NO. 15/570,072 PREVIOUSLY RECORDED AT REEL: 044910 FRAME: 0507. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER AND CHANGE OF NAME. Recorded May 3, 2021
From: NOVADAQ TECHNOLOGIES INC.
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 056425/0530 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 052873/0548 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 052873/0597 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 053318/0612 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 053823/0445 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 7, 2020
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 052860/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2019
From: FLOWER, ROBERT W.; STEAD, ROBERT ANTHONY; BAILEY, ARTHUR E.
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 049303/0913 →
MERGER AND CHANGE OF NAME Recorded Dec 19, 2017
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 044910/0507 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FUNDING IV TRUST (AS SUCCESSOR AGENT TO MIDCAP FINANCIAL TRUST)
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043786/0344 →
RELEASE OF SECURITY INTEREST Recorded Sep 8, 2017
From: MIDCAP FINANCIAL TRUST
To: NOVADAQ TECHNOLOGIES INC.; NOVADAQ CORP.
Reel/Frame 043788/0799 →